Sunday, November 5, 2017
- 9:00AM-11:00AM
-
Abstract Number: 23
Auto-Reactive B Cells Escape Peripheral Tolerance Checkpoints in Patients with PR3-ANCA Associated Vasculitis
B Cell Biology and Targets in Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 747
Autoantibodies to Rpp25 (Th/To) Are Specific Markers for Systemic Sclerosis and Are Associated with Limited Cutaneous Disease and Young Age at Disease Onset
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster I- 9:00AM-11:00AM
-
Abstract Number: 130
Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks Who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 33
B Cell Abnormalities in Patients with Chronic Cutaneous Lupus Erythematosus
B Cell Biology and Targets in Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 807
B Cells in Giant Cell Arteritis: a Novel Target for Treatment?
Vasculitis Poster I: Large Vessel Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 40
B-Cell Attracting Chemokine-1 (BCA-1) and Macrophage Inflammatory Protein-3 Alpha (MIP-3α) Act Synergistically in the Recruitment of B Cells in the Rheumatoid Synovium
B Cell Biology and Targets in Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 35
B-Cell Subset Differences in Inflammatory Rheumatic Diseases
B Cell Biology and Targets in Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 56
Baicalein, a Plant-Derived Small Molecule, Activate Nrf2/Autophagy Signaling Axis Via MEK1/2-ERK1/2-Elk1 Pathway to Suppress the Expression of IL-6 in Human Osteoarthritis Chondrocytes
Biology and Pathology of Bone and Joint Poster I- 9:00AM-11:00AM
-
Abstract Number: 415
Baricitinib Reduces GlycA Levels in Phase 2 and Phase 3 Clinical Trials in Patients with Moderate to Severe Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response- 9:00AM-11:00AM
-
Abstract Number: 225
Barriers to the Use of Methotrexate in Ethiopia: Survey of Pharmacy Providers
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 436
Baseline Anemia As a Predictor of Radiographic Progression in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analyses from Two Phase 3 Trials
Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response- 9:00AM-11:00AM
-
Abstract Number: 134
Baseline Characteristics and Rates of Hospitalized Infections in Patients with Rheumatoid Arthritis Treated with Non-TNF Inhibitors in Denmark and Sweden
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 672
Baseline Hyperuricemia As a Predictive Value for Development of Lupus Nephritis in Premenopausal SLE Patients
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 610
Baseline Structural Damage Predicts Response to Abatacept in Patients with Psoriatic Arthritis: A Post Hoc Analysis from a Phase III Study